You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

Details for Patent: 9,714,258


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,714,258 protect, and when does it expire?

Patent 9,714,258 protects AUGTYRO and is included in one NDA.

This patent has sixty-one patent family members in thirty countries.

Summary for Patent: 9,714,258
Title:Diaryl macrocycles as modulators of protein kinases
Abstract:The present invention relates to certain diaryl macrocyclic compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating cancer, pain, neurological diseases, autoimmune diseases, and inflammation.
Inventor(s):Cui Jingrong Jean, Li Yishan, Rogers Evan W., Zhai Dayong
Assignee:TP Therapeutics, Inc.
Application Number:US15113583
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,714,258

Introduction to Patent 9,714,258

United States Patent 9,714,258, titled "Diaryl macrocycles as modulators of protein kinases," is a patent that delves into the development and application of specific chemical compounds. Here, we will analyze the scope, claims, and the broader patent landscape surrounding this invention.

Overview of the Invention

The patent describes certain diaryl macrocyclic compounds, their pharmaceutical compositions, and methods of using these compounds as modulators of protein kinases. Protein kinases are enzymes that play crucial roles in various cellular processes, and their dysregulation is often associated with diseases such as cancer and inflammatory disorders[2].

Scope of the Patent

Chemical Compounds

The patent focuses on a class of diaryl macrocyclic compounds, which are characterized by their specific chemical structures. These compounds include various functional groups such as alkyl, fluoro, ethenopyrazolo, methyl, tetrahydro, and others. The detailed description of these compounds highlights their potential therapeutic applications, particularly in modulating protein kinase activity[2].

Pharmaceutical Compositions

The patent also covers pharmaceutical compositions containing these diaryl macrocyclic compounds. These compositions can include various excipients, formulations, and delivery methods, which are essential for the effective administration of the compounds in a clinical setting.

Methods of Use

The methods of using these compounds are a critical aspect of the patent. It outlines how these diaryl macrocyclic compounds can be used to treat or prevent diseases associated with protein kinase dysregulation. This includes detailed protocols for administration, dosage, and potential combination therapies.

Claims of the Patent

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims typically cover the specific chemical structures of the diaryl macrocyclic compounds, their pharmaceutical compositions, and the methods of using these compounds. For example, Claim 1 might describe a specific diaryl macrocyclic compound with particular functional groups, while Claim 2 might describe a pharmaceutical composition containing this compound.

Dependent Claims

Dependent claims further narrow down the scope of the independent claims by adding additional limitations or features. For instance, a dependent claim might specify a particular dosage form or a specific method of administration.

Patent Landscape Analysis

Importance of Patent Landscape Analysis

Patent landscape analysis is crucial for understanding the broader technological and competitive landscape surrounding a patent. This analysis involves analyzing vast amounts of patent data to extract valuable legal, business, and technical insights[3].

Key Elements of Patent Landscape Analysis

  • Application Number, Filing Date, and Country: These details help identify the patent and its status in different countries.
  • Legal Status: This includes whether the patent is alive, pending, lapsed, revoked, or expired.
  • Expected Expiry Dates: Knowing when patents are expected to expire is vital for planning and strategy.
  • Patent Trends and Market Developments: This includes mergers and acquisitions, in/out-licensing, litigation, and opposition activities.

Tools and Resources

Several tools and resources are available for conducting a thorough patent landscape analysis:

  • Patent Public Search: A web-based tool provided by the USPTO that offers enhanced access to prior art[4].
  • Global Dossier: A service that provides access to the file histories of related applications from participating IP Offices[4].
  • Common Citation Document (CCD): Consolidates prior art cited by all participating offices for the family members of a patent application[4].

Competitive Landscape

Identifying Competitors

The patent landscape analysis helps in identifying competitors who are also working on similar technologies. This can include other pharmaceutical companies or research institutions that have filed patents related to protein kinase modulators.

Market Developments

Understanding market developments such as mergers and acquisitions, licensing agreements, and litigation activities can provide insights into the competitive dynamics. For example, if a competitor has recently acquired a company with a similar patent portfolio, it could indicate a shift in the market strategy.

Legal and Business Implications

Patent Validity and Enforcement

The legal status of the patent, including its validity and any potential challenges or oppositions, is crucial for business strategy. Ensuring that the patent is valid and enforceable is essential for protecting intellectual property rights.

Licensing and Collaboration

The patent landscape analysis can also reveal opportunities for licensing or collaboration. If other companies have complementary patents, there may be opportunities for cross-licensing agreements or joint development projects.

Conclusion

United States Patent 9,714,258 is a significant invention in the field of pharmaceuticals, particularly in the modulation of protein kinases. Understanding the scope and claims of this patent, along with a thorough patent landscape analysis, is essential for navigating the competitive landscape and making informed business decisions.

Key Takeaways

  • Specific Chemical Compounds: The patent focuses on diaryl macrocyclic compounds with specific functional groups.
  • Pharmaceutical Compositions: The patent covers various pharmaceutical compositions and delivery methods.
  • Methods of Use: Detailed methods for using these compounds in treating diseases associated with protein kinase dysregulation.
  • Patent Landscape Analysis: Essential for understanding the competitive landscape, market developments, and legal implications.
  • Tools and Resources: Utilize tools like Patent Public Search, Global Dossier, and CCD for comprehensive analysis.

FAQs

Q1: What is the main focus of United States Patent 9,714,258? A1: The main focus is on diaryl macrocyclic compounds as modulators of protein kinases.

Q2: What are the key elements of patent landscape analysis? A2: Key elements include application number, filing date, country, legal status, expected expiry dates, and market developments.

Q3: How can patent landscape analysis help in business strategy? A3: It helps in identifying competitors, understanding market developments, and revealing opportunities for licensing or collaboration.

Q4: What tools are available for conducting patent landscape analysis? A4: Tools include Patent Public Search, Global Dossier, and Common Citation Document (CCD).

Q5: Why is it important to know the legal status of a patent? A5: Knowing the legal status ensures that the patent is valid and enforceable, protecting intellectual property rights.

Sources

  1. U.S. Patent and Trademark Office (USPTO) | USAGov
  2. US9714258B2 - Diaryl macrocycles as modulators of protein kinases - Google Patents
  3. Navigating Technological Domains with Patent Landscape Analysis - Sagacious Research
  4. Search for patents - USPTO

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,714,258

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bristol AUGTYRO repotrectinib CAPSULE;ORAL 218213-001 Nov 15, 2023 RX Yes Yes 9,714,258 ⤷  Subscribe Y Y ⤷  Subscribe
Bristol AUGTYRO repotrectinib CAPSULE;ORAL 218213-002 Jun 11, 2024 RX Yes No 9,714,258 ⤷  Subscribe Y Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.